Olfactory bulb atrophy in migraine patients

Objective Osmophobia and headache triggered by odors are commonly seen in migraine, and these are symptoms that differentiate migraine from other primary headaches. Since these odor-related symptoms are disease-specific, we aimed to measure the volume of olfactory bulb and depth of olfactory sulcus...

Full description

Saved in:
Bibliographic Details
Published in:Neurological sciences 2019-01, Vol.40 (1), p.127-132
Main Authors: Aktürk, Tülin, Tanık, Nermin, Serin, Halil İbrahim, Saçmacı, Hikmet, İnan, Levent Ertuğrul
Format: Article
Language:English
Subjects:
Anxiety
Atrophy
Classification
Headache
Magnetic resonance imaging
Medicine
Medicine & Public Health
Mental depression
Migraine
Neuroimaging
Neurology
Neuroradiology
Neurosciences
Neurosurgery
NMR
Nuclear magnetic resonance
Odor
Olfactory bulb
Original Article
Psychiatry
Smell
Statistical analysis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective Osmophobia and headache triggered by odors are commonly seen in migraine, and these are symptoms that differentiate migraine from other primary headaches. Since these odor-related symptoms are disease-specific, we aimed to measure the volume of olfactory bulb and depth of olfactory sulcus in migraine patients. Patients and method A total of 93 subjects, consisting of 62 episodic migraine (32 with osmophobia, 30 without osmophobia) patients and 31 healthy controls, were included in this study. Diagnosis and classification of migraine were performed according to the beta version criteria of International Classification of Headache Disorders (ICHD-3 Beta version). Beck depression and beck anxiety inventory were applied to the patients, and the measurement of bilateral olfactory bulb volume (OBV) and olfactory sulcus depth (OSD) was performed manually in the brain magnetic resonance imaging (MRI). Results More significantly in the left OBV, low OBV has been determined in migraine patients compared to the control group ( p  
ISSN:1590-1874
1590-3478
DOI:10.1007/s10072-018-3597-6